WETS
HUMA icon

Wealth Enhancement Trust Services’s Humacyte HUMA Stock Holding History

Wealth Enhancement Trust Services’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199 Buy
+255
New +$236 ﹤0.01% 1360

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return

Wealth Enhancement Trust Services's HUMA Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Humacyte (HUMA) in Q2 2026: 255 shares worth $199. The stake represents ﹤0.01% of the portfolio and ranks #1360 among its holdings.

94 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Wealth Enhancement Trust Services held 255 shares of Humacyte worth $199 as of Q2 2026.
  • Humacyte was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Humacyte made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1360 holding.
  • 94 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.